BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15548915)

  • 1. Contemporary management of spasmodic dysphonia.
    Sulica L
    Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):543-8. PubMed ID: 15548915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for the treatment of spasmodic dysphonia.
    Gibbs SR; Blitzer A
    Otolaryngol Clin North Am; 2000 Aug; 33(4):879-94. PubMed ID: 10918666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin for spasmodic dysphonia.
    Rodriquez AA
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):767-79. PubMed ID: 14580036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ventricular dysphonia with botulinum toxin.
    Kendall KA; Leonard RJ
    Laryngoscope; 1997 Jul; 107(7):948-53. PubMed ID: 9217137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to botulinum toxin injections for spasmodic dysphonia.
    Smith ME; Ford CN
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):533-5. PubMed ID: 10772310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.
    Watts C; Nye C; Whurr R
    Clin Rehabil; 2006 Feb; 20(2):112-22. PubMed ID: 16541931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies.
    Whurr R; Nye C; Lorch M
    Int J Lang Commun Disord; 1998; 33 Suppl():327-9. PubMed ID: 10343714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spasmodic dysphonia: An overview of clinical features and treatment options.
    Sanuki T
    Auris Nasus Larynx; 2023 Feb; 50(1):17-22. PubMed ID: 35697560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of using botulism toxin in the treatment of spasmodic dysphonia].
    Larrosa F; Idígora A; Aguilar F; Riera L; Martí MJ; Valls J
    Acta Otorrinolaringol Esp; 2002 Jan; 53(1):27-31. PubMed ID: 11998515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.
    Miller RH; Woodson GE; Jankovic J
    Arch Otolaryngol Head Neck Surg; 1987 Jun; 113(6):603-5. PubMed ID: 3566940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia.
    Meleca RJ; Hogikyan ND; Bastian RW
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):487-92. PubMed ID: 9374172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series.
    Blitzer A
    Eur J Neurol; 2010 Jul; 17 Suppl 1():28-30. PubMed ID: 20590805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
    Maloney AP; Morrison MD
    J Otolaryngol; 1994 Jun; 23(3):160-4. PubMed ID: 8064952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic difficulties in spasmodic dysphonia--case report].
    Szkiełkowska A; Miaśkiewicz B; Baczyńska-Swierczyńska S; Szymańska E
    Pol Merkur Lekarski; 2006 May; 20(119):557-9. PubMed ID: 16875162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphonia.
    Galardi G; Guerriero R; Amadio S; Leocani L; Teggi R; Melloni G; Comi G
    Neurol Sci; 2001 Aug; 22(4):303-6. PubMed ID: 11808853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemodenervation of the Larynx.
    Kaye R; Blitzer A
    Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29099066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia.
    Ludlow CL; Naunton RF; Sedory SE; Schulz GM; Hallett M
    Neurology; 1988 Aug; 38(8):1220-5. PubMed ID: 3399071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.